Author(s):
Amoura M. Abou-El-Naga, Saad S Al-Dujaily, Ahmed Badawy, Sarah N Jasim
Email(s):
sa_1995m@yahoo.com
DOI:
10.52711/0974-360X.2025.00364 
Address:
Amoura M. Abou-El-Naga1, Saad S Al-Dujaily2, Ahmed Badawy3, Sarah N Jasim1,4
1Zoology Department, Mansoura University, Egypt.
2High Institute for Infertility Diagnosis and ART, Al-Nahrain University, Iraq.
3College of Medicine, Mansoura University, Egypt.
4The University of Mashreq, Baghdad, Iraq.
*Corresponding Author
Published In:
Volume - 18,
Issue - 6,
Year - 2025
ABSTRACT:
Polycystic ovarian syndrome (PCOS) is a prevalent and complex endocrine condition that affects 5 to 20% of reproductive-age women and is a leading cause of hirsutism and infertility. Selected 100 women were intentionally divided, according to the cause of infertility, into 50 infertile women with polycystic ovarian syndrome (PCOS) and 50 nonpolycystic ovarian syndromes (Male factor) used as a control group. For each patient, measurement of Activin A, Fibrillin-3 hormones, and Betacillulin growth factor in serum was done on: The day of the ovum collection and the day of the embryo transfer (ET). In follicular fluid on the day of the ovum collection. Human ACV-A, FIB-3, and BTC growth factor ELISA kits of Sunlong biotech products allow for the in vitro quantitative determination of human ACV-A(3.4-200pg/ml), FBN-3(1.6-65ng/ml), and BTC growth factor (38-2000pg/ml) concentrations in serum and follicle fluid. Fifty subfertile women were diagnosed with polycystic ovary syndrome (PCOS) and 50 infertile women had no PCOS (male factor). There was no significant(P>0.05) difference in the mean age between the non-PCOS group and the PCOS group, (30.44± 3.89 versus 31.16± 2.41years). Highly significant differences were encountered between PCOS and Non –PCOS groups when we measured, serum and follicular of (ACT a, FBN-3, BTC) on the day of ova pickup(OPU), serum of (ACT a, FBN-3, BTC) on the day of embryo transfer. All these variables were highly significantly (P<0.001) higher in PCOS groups in comparison with non-PCOS groups for ACT a, while these variables were highly significantly (P<0.001) in non-PCOS groups in comparison with PCOS groups for (FBN-3, BTC).
Cite this article:
Amoura M. Abou-El-Naga, Saad S Al-Dujaily, Ahmed Badawy, Sarah N Jasim. Role of Activin A, Fibrillin-3 Hormone and Betacellulin Growth Factor on Implantation Rate in PCOS and Non-PCOS Women Undergo ART. Research Journal of Pharmacy and Technology. 2025;18(6):2548-4. doi: 10.52711/0974-360X.2025.00364
Cite(Electronic):
Amoura M. Abou-El-Naga, Saad S Al-Dujaily, Ahmed Badawy, Sarah N Jasim. Role of Activin A, Fibrillin-3 Hormone and Betacellulin Growth Factor on Implantation Rate in PCOS and Non-PCOS Women Undergo ART. Research Journal of Pharmacy and Technology. 2025;18(6):2548-4. doi: 10.52711/0974-360X.2025.00364 Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-6-17
REFERENCES:
1. Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016; 2: 16057.2.
2. Gunning MN, Fauser BCJM. Are women with polycystic ovary syndrome at increased cardiovascular disease risk later in life? Climacteric. 2017; 20(3): 222-7.
3. Radhakrishnan SA. Polycystic Ovarian Syndrome (PCOS) in Adolescence. Asian J. Nur. Edu. & Research. 2012; 2(2): 55-64.
4. Sheela Williams, Lissa J, Saraswathi. K. N. A Study to assess the Effectiveness of Structured Teaching Programme on Knowledge Regarding Polycystic Ovarian Disease among Adolescent Girls in Selected Colleges in Mysuru. Asian J. Nur. Edu. and Research. 2017; 7(3): 371-375.
5. Ashlesha Nagare, Mercy Anjore. To Assess the Effectiveness of Planned Teaching Programme on Knowledge regarding Polycystic Ovarian Syndrome, its Management and Prevention among Late Adolescent Girls in selected Undergraduate Colleges of Nagpur City. Asian J. Nursing Education and Research. 2019; 9(1): 01-03.
6. Nancychandra Priya P., Shwetha M. N.. Knowledge regarding Polycystic Ovarian Syndrome among Young Female Adults. Asian J. Nursing Education and Research. 2019; 9(1): 84-86.
7. Yashoda Shrivastava, Parvati Jagdev. A Study to assess the Effectiveness of self Instructional module on Knowledge regarding Polycystic Ovarian Syndrome among B.Sc. Nursing students of Selected nursing college. Asian J. Nursing Education and Research. 2019; 9(3): 388-390.
8. SanasamBirjeni Devi, C. Susila. Diagnosis, causal factors and associated diseases of PCOS: A Mini-review. Asian Journal of Nursing Education and Research. 2022; 12(1): 138-3.
9. Usama Shoukath, Umama Shoukath, Salma Sultana, Mohammed NayeemUddin. Polycystic Ovary Syndrome (PCOS): A Thief of Womenhood. Asian J. Res. Pharm. Sci. 2018; 8(2): 68-72.
10. AkshayGade, RutujaSawant, ShreyaParkar, PrajaktaKegade. Polycystic ovary syndrome: An Overview, Diagnosis and Treatment of PCOS. Asian J. Pharm. Tech. 2020; 10(4): 265-272.
11. Khushboo Brar, Tarundeep Kaur, P. Vadivukarrasi Ramanadin . Knowledge regarding Poly Cystic Ovarian Syndrome (PCOS) among the Teenage Girls. Int. J. Nur. Edu. and Research. 2016; 4(2): 136-140.
12. Asha K Varughese, Veena Greetta Tauro. Polycystic Ovarian Syndrome – An Overview. Int. J. Nur. Edu. and Research. 2019; 7(4): 601-604.
13. Fortin J, Boehm U, Deng C-X, Treier M, Bernard DJ. Follicle-stimulatinghormone synthesis and fertility depend on SMAD4 and FOXL2. The FASEBJournal. 2014; 28(8): 3396-3410.
14. Shaw ND, Histed SN, Srouji SS, Yang J, Lee H, Hall JE. Estrogen Negative Feedback on Gonadotropin Secretion: Evidence for a Direct Pituitary Effect in Women. The Journal of Clinical Endocrinology and Metabolism. 2010; 95(4): 1955-1961.
15. Rozario T. and De Simone DW,et al.The extracellular matrix in development and morphogenesis:a dynamic view.Dev.Biol. 2010; 341: 126-140.
16. Urbanek M, Sam S, Legro RS,et al. Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype. J Clin Endocrinol Metabol. 2007; 92 (11): 4191-4198.
17. Society for assisted Reproduction and Technology. Assisted reproductive technology in the United States and Canada. Results generated from American Society for Reproductive Technology Registry. Fertil Steril. 1998; 69: 389-98.
18. Alvarez C, Garrido CG, Taronger R, et al. In vitro maturation,fertilization,embryo development and clinical outcome of human metaphase-I oocyte retrieved from stimulated intracytoplasmic sperm injection cycles. Indian J Med Res. 2013; 137: 331-338.
19. Fatemi HM, Polyzos NP, Van Vaerenbergh I, et al. Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles. Fertil Steril. 2013; 100: 742-7.
20. Griffith OW, Chavan AR, Protopapas S, Maziarz J, Romero R and Wagner GP. Embryo implantation evolved from an ancestral inflammatory attachment reaction. Proc. Natl. Acad. Sci. U.S.A. 2017; 114: E6566-E6575. PMID: 28747528 DOI
21. Implantation stages. Human Embryology. Online course in embryology for medicine students developed by the universities of Fribourg, Lausanne and Bern (Switzerland) with the support of the Swiss Virtual Campus. Retrieved 6 December 2011.
22. Endometriosis: Condition Information. nichd.nih.gov. Archived from the original on 30 April 2017. Retrieved 20 May 2017.
23. Endometriosis. womenshealth.gov. 13 February 2017. Archived from the original on 13 May 2017. Retrieved 20 May 2017.
24. Begum BN, Hasan S. Psychological problems among women with infertility problem: a comparative study. Journal of Pakistan Medical Association. 2014; 64(11): 1287–1291
25. Direkvand-Moghadam A, Delpisheh A, Direkvand-Moghadam A. Effect of Infertility on the Quality of Life, A Cross- Sectional Study. Journal of Clinical and Diagnostic Research. 2014; 8(10): OC13-OC15.
26. Pagliardini L, Vigano’ P, Molgora M. High Prevalence of Vitamin D Deficiency in Infertile Women Referring for Assisted Reproduction. Nutrients. 2015; 7(12): 9972-9984.
27. Al-Turki H A. Prevalence of primary and secondary infertility from tertiary center in eastern Saudi Arabia. Middle East Fertility Society Journal. 2015; 20 (4): 237–240.
28. Sathya A, Balasubramanyam S, Gupta S, et al. Effect of body mass index on in vitro fertilization outcomes in women.Journal of Human Reproductive Sciences. 2010; 3(3): 135-138.
29. Ji S Z, Xiao-Ping C, Xiang WW.Correlation analysis of inhibin B, follistatin and activin A in patients with polycystic ovary syndrome. African Journal of Microbiology Research. 2010; 4(12): 1295-1298.
30. Eldar-Geva T, Spitz IM, Groome NP, Margalioth EJ, Homburg R. Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome. Human Reproduction. 2001; 16: 2552–2556.
31. Norman RJ, Milner CR, Groome NP, Robertson DM. Circulating follistatin concentrations are higher and activin concentrations are lower in polycystic ovarian syndrome. Human Reproductio. 2001; 16: 668-672.
32. Magoffin DA, Jakimiuk AJ. Inhibin A, inhibin B and activinAconcentrations in follicular fluid from women with polycystic ovary syndrome. Human Reproductio. 1998; 13: 2693–2698.
33. El-Shafey M1, Hegazy M, El-Zahabi M. Clinical Significance of Follistatin in Obese and Non-obese Egyptian Polycystic Ovarian Patients. Journal of Molecular Pathophysiology. 2016; 2 (1): 10-14.
34. Lockwood GM, Muttukrishna S, Groome NP, Knight PG, Ledger WL. Circulating inhibins and activin A during GnRH-analogue down-regulation and ovarian hyperstimulation with recombinant FSH for in-vitro fertilization-embryo transfer. Clinical Endocrinology (Oxford). 1996; 45(6): 741–748.
35. Dumesic DA, Abbott DH. Implications of polycystic ovary syndrome on oocyte development. Seminars in Reproductive Medicine. 2008; 26: 53–61.
36. Al-Dujaily SS, Rasha F. Role of Fibrillin-3,Follistatin, andActivin-A Hormones on Fertilization Capacityof Infertile Women in IVF Programs. 2015
37. Refaat B. Role of activins in embryo implantation and diagnosis ofectopic pregnancy. Reprod Biol Endocrinol. 2014; 12: 116.
38. Jordan CD, Bohling SD, Charbonneau NL, et al. Fibrillins in adult human ovary and polycystic ovary syndrome: Is Fibrillin-3 affected in PCOS? J. Histochem. Cytochem. 2010; 58: 903-915.
39. Sabatier L, Miosge N, Hubmacher D, Lin G, et al. Fibrillin-3 expression in human development. Matrix Biol. 2011; 30 (1): 43-52.
40. Al-Dujaily SS, Mohammed W. Role of fibrillin-3 in fertilization capacity in womenundergoing intrauterine insemination. IJEIR. 2014; 6(2): 34-39.
41. Park JY, Su YQ, Ariga M, Law E, Jin SL, Conti M. EGF-like growth factors as mediators of LH action in the ovulatory follicle. Science 2004; 303: 682–4.
42. Ashkenazi H, Cao X, Motola S, Popliker M, Conti M, Tsafriri A. Epidermal growth factor family members: endogenous mediators of the ovulatory response. Endocrinology 2005; 146: 77–84.
43. Nyholt de Prada JK, Lee YS, Latham KE, Chaffin CL, VandeVoort CA. Role for cumulus cell-produced EGF-like ligands during primate oocyte maturation in vitro. Am J Physiol Endocrinol Metab. 2009; 296: E1049–58
44. Fang L, Cheng JC, Chang HM, Sun YP, Leung PC. EGF-like growth factors induce COX-2-derived PGE2 production through ERK1/2 in human granulosa cells. J Clin Endocrinol Metab. 2013; 98: 4932–41
45. Conti M, Hsieh M, Zamah AM, Oh JS. Novel signaling mechanisms in the ovary during oocyte maturation and ovulation. Mol Cell Endocrinol. 2012; 356: 65–73.
46. Guzeloglu-Kayisli O, Lalioti MD, Aydiner F, Sasson I, Ilbay O, Sakkas D, et al. Embryonic poly(A)-binding protein (EPAB) is required for oocyte maturation and female fertility in mice. Biochem J. 2012; 446:47–58.
47. Das SK, Das N, Wang J, Lim H, Schryver B, Plowman GD, et al. Expression of betacellulin and epiregulin genes in the mouse uterus temporally by the blastocyst solely at the site of its apposition is coincident with the window of implantation. DevBiol. 1997; 190:178–90.
48. Schneider MR, Wolf E. The epidermal growth factor receptor and its ligands in female reproduction: insights from rodent models. Cytokine Growth Factor Rev. 2008; 19:173–81.